SSelectStock

JSLLJeena Sikho Lifecare Limited

Healthcare · Medical Care Facilities · NSE · as of 2026-09-11 (delayed ~30 min in market hours)

Jeena Sikho Lifecare Limited trades in ayurvedic medicines in India. The company offers ayurvedic products under the Shuddhi brand name. It also provides services, including in-patient, out-patient, 72 hours health camps, Panchakarma therapies, dietary support and nutrition guidance, home-based healthcare services, and healthcare support centre services. In addition, the company operates clinics under the Shuddhi Ayurveda, Shuddhi Clinics, Hospital & Institution of Integrated Medical Sciences, Shuddhi Wellness Clinics & Hospital, Shuddhi Ayurveda Panchakarma Hospital, and Shuddhi Panchakarma Day Care Clinic names. Jeena Sikho Lifecare Limited was founded in 2009 and is headquartered in Zirakpur, India.

511.85
1.24%
49Average

Mkt Cap
₹6,387 Cr
P/E
28.7
P/B
13.6
Div Yield
0.17%
52W High
₹849.50
52W Low
₹492.00

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)6,386.60
P/E28.72
P/B13.62
PEG1.01
ROE %47.50
ROCE %50.80
Debt / Equity0.27
EPS17.82
Revenue Growth %28.80
Profit Growth %28.40
Dividend Yield %0.17
Promoter Holding %74.72
FII Holding %0.30
DII Holding %
Beta1.07

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

None of the 16 pattern scanners currently detects a setup on JSLL — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.

HOLDConviction 51%

The picture

  • Revenue growth: 28.8% YoY
  • Profit growth: 28.4% YoY
  • ROE: 47.5%
  • MACD: bullish
  • Beta: 1.06
  • Liquidity: ₹25.1 cr avg turnover

Bull case

  • Revenue growth: 28.8% YoY
  • Profit growth: 28.4% YoY
  • ROE: 47.5%
  • MACD: bullish

Bear case

  • Dividend yield: 0.17%
  • Price vs EMA21: below
  • Price vs SMA50: below
  • 1-month return: -3.3%

Key risks

  • Momentum is fading versus the broader market
  • Dividend yield: 0.17%
  • Price vs EMA21: below

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹511.85
Stop Loss
₹489.41
risk 4.4%
Target 1 (1.5R)
₹545.52
+6.6%
Target 2 (3R)
₹579.18
+13.2%
Support (20d)
₹494.35
Resistance (52w)
₹849.50
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹22.44/share
ATR (volatility)
₹19.49
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹19.49). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental96
Technical31
Momentum13
Risk (safety)48

Peers — Healthcare

GKSL 1.23%
79
NEPHROPLUS 2.42%
74
KOVAI 1.41%
73
SAILIFE 0.38%
73
METROPOLIS 1.70%
73
VIJAYA 0.21%
72